INFLUENCE OF HIGH-DOSE ATORVASTATIN ON BILE ACID METABOLISM IN MICE WITH LIVER INJURY AND RELATED MECHANISM

INFLUENCE OF HIGH-DOSE ATORVASTATIN ON BILE ACID METABOLISM IN MICE WITH LIVER INJURY AND RELATED MECHANISM

Objective To investigate the influence of high-dose atorvastatin on bile acid metabolism in mice with liver injury and its mechanism. Methods A total of 40 specific pathogen-free male C57BL/6 mice were randomly divided into normal saline group (group A) and low-, middle-, and high-dose atorvastatin...

Full description

Bibliographic Details
Main Author:	XIA Feifei, SONG Bingxue, SONG Yuqing, TIAN Jiawei, YAN Hui, HUANG Yuxiao, XIN Hui, LIANG Hui
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2023-10-01
Series:	精准医学杂志
Subjects:	atorvastatin\|chemical and drug induced liver injury\|bile acid\|metabolism\|gene expression
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/202305002.pdf

Similar Items

Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice
by: Wen-Kai Li, et al.
Published: (2017-05-01)

CHANGE IN INTESTINAL FLORA AND ITS ASSOCIATION WITH LIVER CYP2E1 IN MICE WITH LIVER INJURY INDUCED BY HIGH-INTENSITY ATORVASTATIN
by: SONG Bingxue, SONG Yuqing, LIU Xin, YU Haichu, XIN Hui, LIANG Hui
Published: (2023-12-01)

Clinical Characteristics of Liver Injury Induced by Atorvastatin
by: JIANG Linshuang, CHEN Maowei
Published: (2024-10-01)

Histological Alterations Induced by Atorvastatin Therapeutic Doses in some Organs of Male Albino Rats
by: Twana Ahmed Mustafa, et al.
Published: (2019-04-01)

Comparison between effects of different doses of Melissa officinalis and atorvastatin on the activity of liver enzymes in hypercholesterolemia rats
by: Saeed Changizi Ashtiyani, et al.
Published: (2014-01-01)

Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers
by: Jimme K. Wiggers, et al.
Published: (2017-04-01)

Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
by: Haitham Galal, et al.
Published: (2015-12-01)

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)

Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury
by: Zhongyang Xie, et al.
Published: (2021-12-01)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
by: Samad Golshani, et al.
Published: (2022-01-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Melatonin attenuates cholestatic liver injury by improving bile acid metabolism in mice
by: ZHANG Hongjia, et al.
Published: (2024-06-01)

Atorvastatin combined with low-dose dexamethasone improves the neuroinflammation and survival in mice with intracerebral hemorrhage
by: Yiming Song, et al.
Published: (2022-08-01)

Preventive effects of different doses of atorvastatin on contrast-induced acute kidney injury in patients after multiple CT perfusions
by: Ning Cui, et al.
Published: (2022-03-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

LIVER TRANSPLANTATION FOR BILE DUCT INJURY AFTER CHOLECYSTECTOMY
by: José Francisco Rêgo e SILVA FILHO, et al.

Statin-induced myopathy associated with atorvastatin therapy in the elderly patient. Clinical case
by: Natalia A. Cherkasova, et al.
Published: (2021-10-01)

Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health
by: Jin-Jin Cui, et al.
Published: (2023-08-01)

Multiparticulate Systems of Ezetimibe Micellar System and Atorvastatin Solid Dispersion Efficacy of Low-Dose Ezetimibe/Atorvastatin on High-Fat Diet-Induced Hyperlipidemia and Hepatic Steatosis in Diabetic Rats
by: Carlos Torrado-Salmerón, et al.
Published: (2021-03-01)

The long-term impact of post-cholecystectomy major bile duct injury on liver stiffness
by: Avinash Jayasekara, et al.
Published: (2024-11-01)

Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
by: Saeed Kalantari, et al.
Published: (2014-01-01)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
by: Ghim JL, et al.
Published: (2019-05-01)

Low-Dose Atorvastatin has Promoting Effect on Melanoma Tumor Growth and Angiogenesis in Mouse Model
by: Golnaz Vaseghi, et al.
Published: (2023-01-01)

Disorders peculiarities of the bile-formed and bile-excreting liver functions in the early period of traumatic disease on the background of chronic hepatitis
by: R. Blyzniuk, et al.
Published: (2015-10-01)

Disorders peculiarities of the bile-formed and bile-excreting liver functions in the early period of traumatic disease on the background of chronic hepatitis
by: R. Blyzniuk, et al.
Published: (2015-10-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

Can atorvastatin calcium cause asymptomatic hypercalcemia?
by: Suleyman Hilmi Ipekci, et al.
Published: (2014-10-01)

Evaluation of periodontal health in patients taking atorvastatin
by: Kosar Rezaei Talarposhti, et al.
Published: (2018-09-01)

Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism
by: Meilan Xue, et al.
Published: (2021-04-01)

Evaluating the Proposed Mechanism by Which Atorvastatin Can Protect Renal Tissue against Contrast Media: An Animal study
by: Samer Jaffar Sharif, et al.
Published: (2019-03-01)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
by: Jaecheol Moon, et al.
Published: (2020-01-01)

The preventive effect of atorvastatin on liver fibrosis in the bile duct ligation rats via antioxidant activity and down-regulation of Rac1 and NOX1
by: Zohreh-al-sadat Ghoreshi, et al.
Published: (2020-01-01)

PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS OF HIGH-DOSE ATORVASTATIN CARDIOPROTECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: I. D. Astrakhantseva, et al.
Published: (2018-09-01)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
by: Yu-Lin Zhang, et al.
Published: (2022-09-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury
by: Yunus Nazli, et al.
Published: (2015-01-01)

The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
by: Ana Salomé Correia, et al.
Published: (2023-04-01)

The Effect of Atorvastatin on Inflammatory Markers in Patients with Type Two Diabetes
by: Afsaneh Talaei, et al.
Published: (2018-08-01)

Effects of Atorvastatin in Patients with Acute Spinal Cord Injury
by: Javad Aghazadeh, et al.
Published: (2017-12-01)

Atorvastatin and carnitine combination versus atorvastatin alone impacts on the lipid profile of haemodialyzed patients: A randomised clinical trial
by: Hamid Noshad, et al.
Published: (2018-12-01)